MEI Pharma, Inc. financial data

Symbol
MEIP on Nasdaq
Industry
Pharmaceutical Preparations
Location
11455 El Camino Real, Suite 250, San Diego, CA
State of incorporation
DE
Fiscal year end
June 30
Former names
MARSHALL EDWARDS INC (to 6/6/2012)
Latest financial report
10-K - Q2 2024 - Sep 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 737 % +30%
Debt-to-equity 30 % -89.7%
Return On Equity 31.6 %
Return On Assets 24.3 %
Operating Margin 22.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.66M shares 0%
Common Stock, Shares, Outstanding 6.66M shares 0%
Entity Public Float 28.7M USD -9.75%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 6.66M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 6.66M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 65.3M USD +33.8%
Research and Development Expense 16.6M USD -68.4%
General and Administrative Expense 23.3M USD -29.7%
Costs and Expenses 50.8M USD -40.7%
Operating Income (Loss) 14.5M USD -71.3%
Nonoperating Income (Expense) 3.24M USD -34.3%
Net Income (Loss) Attributable to Parent 17.8M USD -83.5%
Earnings Per Share, Basic 2.67 USD/shares -82.8%
Earnings Per Share, Diluted 2.67 USD/shares -82.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.71M USD -78.1%
Cash, Cash Equivalents, and Short-term Investments 38.3M USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 40.8M USD -62.1%
Property, Plant and Equipment, Net 392K USD -70.1%
Operating Lease, Right-of-Use Asset 214K USD -98.2%
Assets 41.4M USD -65.8%
Accounts Payable, Current 3.17M USD -48.4%
Employee-related Liabilities, Current 2.82M USD -60.8%
Accrued Liabilities, Current 5.19M USD -58.4%
Liabilities, Current 8.36M USD -58.9%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 8.36M USD -91.3%
Retained Earnings (Accumulated Deficit) -388M USD +4.38%
Stockholders' Equity Attributable to Parent 33M USD +34.1%
Liabilities and Equity 41.4M USD -65.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.5M USD -25.1%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 4.96M USD -63.9%
Common Stock, Shares Authorized 226M shares 0%
Common Stock, Shares, Issued 6.66M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Deferred Tax Assets, Valuation Allowance 69.9M USD -8.24%
Deferred Tax Assets, Gross 69.9M USD -8.24%
Operating Lease, Liability 0 USD -100%
Depreciation 86K USD -11.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 14.6M USD -13.7%
Property, Plant and Equipment, Gross 2.16M USD -7.98%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.48M USD +29.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.91M USD -18.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.96M USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.55M USD +2.99%
Deferred Tax Assets, Operating Loss Carryforwards 45.7M USD +32.5%
Preferred Stock, Shares Issued 100K shares 0%
Preferred Stock, Shares Authorized 100K shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.72M USD +6.43%
Operating Lease, Payments 13.6M USD +500%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 87K USD -12.1%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%